{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:55:56Z","timestamp":1787756156014,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-116441GB-I00"],"award-info":[{"award-number":["PID2020-116441GB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-ONC\/28636\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/28636\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/139178\/2018"],"award-info":[{"award-number":["SFRH\/BD\/139178\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.xcrm.2023.101120","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T12:14:55Z","timestamp":1689250495000},"page":"101120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Co-targeting RANK pathway treats and prevents acquired resistance to CDK4\/6 inhibitors in luminal breast cancer"],"prefix":"10.1016","volume":"4","author":[{"given":"In\u00eas","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M.","family":"Gallego-Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia G.","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Mansinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Gonz\u00e1lez","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-4477","authenticated-orcid":false,"given":"Sandra","family":"Casimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101120_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","article-title":"Differences in breast cancer survival by molecular subtypes in the United States","volume":"27","author":"Howlader","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.xcrm.2023.101120_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918786451","article-title":"CDK4\/6 inhibition in breast cancer: current practice and future directions","volume":"10","author":"Pernas","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.xcrm.2023.101120_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2023.101120_bib4","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.101120_bib5","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3390\/cells10081978","article-title":"The roadmap of RANKL\/RANK pathway in cancer","volume":"10","author":"Casimiro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2023.101120_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature09027","article-title":"Control of mammary stem cell function by steroid hormone signalling","volume":"465","author":"Asselin-Labat","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101120_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101120_bib8","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.0915148107","article-title":"Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland","volume":"107","author":"Beleut","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101120_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-016-4029-z","article-title":"Can we prevent BRCA1-associated breast cancer by RANKL inhibition?","volume":"161","author":"Kotsopoulos","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.xcrm.2023.101120_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/cr.2016.69","article-title":"RANKL\/RANK control Brca1 mutation-driven mammary tumors","volume":"26","author":"Sigl","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm.4118","article-title":"RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers","author":"Nolan","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101120_bib12","doi-asserted-by":"crossref","first-page":"e63153","DOI":"10.1371\/journal.pone.0063153","article-title":"RANKL\/RANK\/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in\u00a0vitro","volume":"8","author":"Casimiro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101120_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101120_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/path.2567","article-title":"Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas","volume":"218","author":"Mikami","year":"2009","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.xcrm.2023.101120_bib15","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1158\/0008-5472.CAN-12-0044","article-title":"RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis","volume":"72","author":"Palafox","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pros.20678","article-title":"RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes","volume":"68","author":"Armstrong","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.xcrm.2023.101120_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10585-013-9624-3","article-title":"RANK expression on breast cancer cells promotes skeletal metastasis","volume":"31","author":"Blake","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.xcrm.2023.101120_bib18","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.1454","article-title":"Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis","volume":"31","author":"Pellegrini","year":"2013","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2023.101120_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1756-9966-32-62","article-title":"Activation of NF-kappaB by the RANKL\/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines","volume":"32","author":"Tsubaki","year":"2013","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib20","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.18632\/oncotarget.27576","article-title":"Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer","volume":"11","author":"Gomes","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2023.101120_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2021.04.022","article-title":"RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness","author":"Benitez","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xcrm.2023.101120_bib22","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1038\/s41467-021-23612-z","article-title":"Clinical CDK4\/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2","volume":"12","author":"Pack","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101120_bib23","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3390\/ijms21082974","article-title":"Blockade of CDK7 reverses endocrine therapy resistance in breast cancer","volume":"21","author":"Attia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2023.101120_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2016.03.012","article-title":"Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide","volume":"83","author":"Abe","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2023.101120_bib25","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1158\/1078-0432.CCR-19-4191","article-title":"Activation of the IFN signaling pathway is associated with resistance to CDK4\/6 inhibitors and immune checkpoint activation in ER-positive breast cancer","volume":"27","author":"De Angelis","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib26","doi-asserted-by":"crossref","first-page":"580251","DOI":"10.3389\/fphar.2020.580251","article-title":"Mechanisms of CDK4\/6 inhibitor resistance in luminal breast cancer","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2023.101120_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fonc.2019.00666","article-title":"Mechanisms of resistance to CDK4\/6 inhibitors: potential implications and biomarkers for clinical practice","volume":"9","author":"McCartney","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2023.101120_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7150\/ijbs.30572","article-title":"Combined Androgen receptor blockade overcomes the resistance of breast cancer cells to palbociclib","volume":"15","author":"Ji","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.xcrm.2023.101120_bib29","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2004-07-2534","article-title":"Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration","volume":"105","author":"Kwak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101120_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101120_bib31","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/1078-0432.CCR-16-3206","article-title":"NeoPalAna: neoadjuvant Palbociclib, a cyclin-dependent kinase 4\/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor-positive breast cancer","volume":"23","author":"Ma","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13058-021-01390-2","article-title":"RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer","volume":"23","author":"Sanz-Moreno","year":"2021","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ccell.2017.11.006","article-title":"Genomic aberrations that activate D-type cyclins are associated with enhanced sensitivity to the CDK4 and CDK6 inhibitor abemaciclib","volume":"32","author":"Gong","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101120_bib34","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41388-020-1284-6","article-title":"Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities","volume":"39","author":"Pancholi","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101120_bib35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/cancers11050684","article-title":"Targeting palbociclib-resistant estrogen receptor-positive breast cancer cells via oncolytic virotherapy","volume":"11","author":"Lypova","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2023.101120_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/genes12020159","article-title":"Deregulated immune pathway associated with palbociclib resistance in preclinical breast cancer models: integrative genomics and transcriptomics","volume":"12","author":"Pandey","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.xcrm.2023.101120_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101120_bib38","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.celrep.2018.02.053","article-title":"The CDK4\/6 inhibitor abemaciclib induces a T\u00a0cell inflamed tumor microenvironment and enhances the Efficacy of PD-L1 checkpoint blockade","volume":"22","author":"Schaer","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101120_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s43018-020-00135-y","article-title":"CDK4\/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity","volume":"2","author":"Watt","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2023.101120_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101120_bib41","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3389\/fimmu.2018.02542","article-title":"Regulatory networks involving STATs, IRFs, and NFkappaB in inflammation","volume":"9","author":"Platanitis","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101120_bib42","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.3892\/or.2015.4294","article-title":"Autocrine interferon-gamma may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor beta subtype","volume":"34","author":"Niu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.xcrm.2023.101120_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2023.101120_bib44","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1038\/s41467-020-20138-8","article-title":"Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T\u00a0cells","volume":"11","author":"G\u00f3mez-Aleza","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101120_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41698-022-00297-1","article-title":"Comparative biomarker analysis of PALOMA-2\/3 trials for palbociclib","volume":"6","author":"Zhu","year":"2022","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.xcrm.2023.101120_bib46","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101120_bib47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101120_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101120_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.101120_bib50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101120_bib51","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.7.10.986","article-title":"The significance of digital gene expression profiles","volume":"7","author":"Audic","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2023.101120_bib52","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101120_bib53","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101120_bib54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123002483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123002483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:56:44Z","timestamp":1762988204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123002483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2666379123002483"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101120","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-targeting RANK pathway treats and prevents acquired resistance to CDK4\/6 inhibitors in luminal breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101120"}}